scholarly journals The Irritable Bowel: A Pathological or a Psychological Syndrome?

1988 ◽  
Vol 81 (12) ◽  
pp. 718-720 ◽  
Author(s):  
D Waxman
Keyword(s):  
Irritable Bowel Syndrome ◽  
Antidepressant Medication ◽  
Bulking Agents ◽  
Case Histories ◽  
Treatment Regimens ◽  
Symptoms Of Depression ◽  
Bowel Symptoms ◽  
Irritable Bowel

The irritable bowel syndrome is discussed together with some of its theories, methods of investigation and various treatment regimens. Eight case histories are reported. In each patient, symptoms appeared to be precipitated by situations interpreted by that patient as stressful. A programme of prospective desensitization using hypnosis is described. Where symptoms of depression were additionally present, antidepressant medication was prescribed. This was subsequently phased out as and when indicated. Where patients had been taking antidiarrhoeal or antispasmodic drugs, various stool bulking agents or benzodiazepines, these were also slowly discontinued as treatment progressed. Cases were followed up from 3 months to 12 years. In 2 cases recurrence of symptoms was again successfully treated. There was no recurrence of any of the bowel symptoms in any other patient. The results support the view that the irritable bowel syndrome is psychogenic in origin.

Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome

2002 ◽  
Author(s):  
AO Quartero ◽  
V Meiniche-Schmidt ◽  
J Muris ◽  
J Neeleman ◽  
G Rubin ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Antidepressant Medication ◽  
Bulking Agents ◽  
Irritable Bowel

scholarly journals A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Martin Aasbrenn ◽  
Stian Lydersen ◽  
Per G. Farup
Keyword(s):  
Body Mass Index ◽  
Morbid Obesity ◽  
Weight Loss ◽  
Irritable Bowel Syndrome ◽  
Cohort Study ◽  
Body Mass ◽  
Prospective Cohort ◽  
Weight Loss Intervention ◽  
Bowel Symptoms ◽  
Irritable Bowel

Background. Irritable bowel syndrome (IBS) is common in subjects with morbid obesity; the effect of weight loss programs on bowel symptoms is largely unknown. Methods. This prospective cohort study explored bowel symptoms, health scores, and biomarkers in subjects with morbid obesity during a six-month-long conservative weight loss intervention. Bowel symptoms were assessed with IBS-severity scoring system (IBS-SSS) and Gastrointestinal Symptom Rating Scale-IBS. Changes in all variables and associations between the changes in bowel symptoms and the other variables were analysed. Results. Eighty-eight subjects (81% females) were included. Body mass index was reduced from 42.0 (3.6) to 38.7 (3.5) (p<0.001). IBS-SSS was reduced from 116 (104) to 81 (84) (p=0.001). In all, 19 out of 25 variables improved significantly. In subjects with and without IBS at inclusion, the improvement in IBS-SSS was 88 (95% CI 55 to 121) and 10 (95% CI −9 to 29), respectively. Improved bowel symptoms were associated with improved subjective well-being, sense of humour, and vitamin D and negatively associated with reduced body mass index. Conclusion. Body mass index and health scores improved during a conservative weight loss intervention. Subjects with IBS before the intervention had a clinically significant improvement in bowel symptoms.

Tu2018 Rectal Compliance, Acclimation, and Bowel Symptoms in Women With Irritable Bowel Syndrome (IBS)

2012 ◽  
Vol 142 (5) ◽  
pp. S-902-S-903
Author(s):  
Sagar R. Shroff ◽  
C. Prakash Gyawali ◽  
Amir Sabzpoushan ◽  
Navya D. Kanuri ◽  
Billy D. Nix ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Rectal Compliance ◽  
Bowel Symptoms ◽  
Irritable Bowel

Cognitive-Behaviour Therapy as a Treatment for Irritable Bowel Syndrome: A Pilot Study

2000 ◽  
Vol 34 (2) ◽  
pp. 300-309 ◽  
Author(s):  
Philip Boyce ◽  
Jemma Gilchrist ◽  
Nicholas J. Talley ◽  
Donna Rose
Keyword(s):  
Irritable Bowel Syndrome ◽  
Symptom Severity ◽  
Cognitive Behaviour Therapy ◽  
Psychological Treatment ◽  
Treatment Compliance ◽  
Behaviour Therapy ◽  
Bowel Symptom ◽  
Bowel Symptoms ◽  
Cognitive Behaviour ◽  
Irritable Bowel

Objective: The irritable bowel syndrome (IBS) is a chronic and often disabling functional bowel disorder. Psychological treatments, in particular cognitive and behavioural interventions, have been shown to be effective for this disorder. The aim of this study was to test the efficacy of a cognitive-behaviour program. Method: Eight participants (seven female, one male) aged between 24 and 71 years, with a diagnosis of IBS according to the Rome criteria, were recruited from among the gastroenterology outpatients at Nepean Hospital, in Sydney, Australia. Participants were administered pretreatment on measures of psychological function and bowel symptom severity. Following a 2-week baseline period, participants began a structured psychological treatment comprising eight sessions of cognitive-behaviour therapy. Throughout treatment, participants maintained daily records of symptom severity and completed homework assignments to ensure treatment compliance. The pretreatment assessment measures were repeated 1 week post-treatment. Results: After treatment, five of the eight patients no longer met the Rome diagnostic criteria for IBS. There was no significant reduction in bowel symptom frequency. There were, however, significant improvements in the distress and disability associated with bowel symptoms. Anxiety and depression were also significantly reduced. Conclusions: Cognitive-behaviour therapy reduced the distress and disability associated with IBS, but not the frequency of bowel symptoms. This supports the proposed cognitive model for IBS, and cognitive-behaviour therapy appears to have its effect by altering the cognitive response to visceral hypersensitivity.

scholarly journals Recommendations on Chronic Constipation (Including Constipation Associated with Irritable Bowel Syndrome) Treatment

2007 ◽  
Vol 21 (suppl b) ◽  
pp. 3B-22B ◽  
Author(s):  
Pierre Paré ◽  
Ronald Bridges ◽  
Malcolm C Champion ◽  
Subhas C Ganguli ◽  
James R Gray ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Health Care Professionals ◽  
Chronic Constipation ◽  
Clinical Care ◽  
Treatment Algorithm ◽  
Treatment Recommendations ◽  
Lifestyle Changes ◽  
Bulking Agents ◽  
Consensus Group ◽  
Irritable Bowel

While chronic constipation (CC) has a high prevalence in primary care, there are no existing treatment recommendations to guide health care professionals. To address this, a consensus group of 10 gastroenterologists was formed to develop treatment recommendations. Although constipation may occur as a result of organic disease, the present paper addresses only the management of primary CC or constipation associated with irritable bowel syndrome. The final consensus group was assembled and the recommendations were created following the exact process outlined by the Canadian Association of Gastroenterology for the following areas: epidemiology, quality of life and threshold for treatment; definitions and diagnostic criteria; lifestyle changes; bulking agents and stool softeners; osmotic agents; prokinetics; stimulant laxatives; suppositories; enemas; other drugs; biofeedback and behavioural approaches; surgery; and probiotics. A treatment algorithm was developed by the group for CC and constipation associated with irritable bowel syndrome. Where possible, an evidence-based approach and expert opinions were used to develop the statements in areas with insufficient evidence. The nature of the underlying pathophysiology for constipation is often unclear, and it can be tricky for physicians to decide on an appropriate treatment strategy for the individual patient. The myriad of treatment options available to Canadian physicians can be confusing; thus, the main aim of the recommendations and treatment algorithm is to optimize the approach in clinical care based on available evidence.

Tu2057 Assessment of Bowel Symptoms, Colonic Transit, and the Relationship to Fecal Bile Acid (BA) Excretion in Health and Irritable Bowel Syndrome (IBS)

2013 ◽  
Vol 144 (5) ◽  
pp. S-915 ◽  
Author(s):  
Andrea Shin ◽  
Michael Camilleri ◽  
Irene A. Busciglio ◽  
Duane D. Burton ◽  
Priya Vijayvargiya ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Bile Acid ◽  
Colonic Transit ◽  
Fecal Bile Acid ◽  
Bowel Symptoms ◽  
Irritable Bowel ◽  
The Relationship
Sign in / Sign up

Export Citation Format

Share Document